Agenus transfers pair of CA production plants to Zydus as part of $141M partnership
Agenus, which has been going through a reorganization after the FDA put the brakes on the biotech's regulatory plan for its cancer combo, inked a deal that transfers two California manufacturing plants to Indian drugmaker Zydus Lifesciences.
Agenus, which has been going through a reorganization after the FDA put the brakes on the biotech's regulatory plan for its cancer combo, inked a deal that transfers two California manufacturing plants to Indian drugmaker Zydus Lifesciences.
